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Cortical and striatal interneurons are both generated within the ventral telencephalon, but their migratory
journey takes them to very different destinations. Two articles in this issue (van den Berghe et al., 2013;
McKinsey et al., 2013) add an important molecular component to our understanding of how, during develop-
ment, interneurons reach the cerebral cortex.The precise execution of the complex
cognitive, sensory, and motor functions of
the mammalian cerebral cortex is depen-
dent on the correct integration of two
main neuronal populations: GABAergic
inhibitory interneurons (INs) and glutama-
tergic excitatory projection neurons (PNs).
GABAergic INs play essential roles in
controlling the response of PNs to afferent
inputs, preventing excessive excitation
and synchronizing the activity of PN
subpopulations. Given their critical modu-
latory functions, it is not surprising that
disruption of interneurons’ fate specifica-
tion, migration, and overall organization
into balanced cortical microcircuitry can
lead to severe pathological conditions
(Levitt et al., 2004, Rossignol, 2011).
Different populations of both cortical
and striatal INs have been fate mapped
to neural progenitors in the medial gangli-
onic eminences (MGEs) (Marı´n and Ru-
benstein, 2001). However, the molecular
mechanisms that control the acquisition
of distinct identities by cortical and striatal
INs and, in particular, how the process
of fate specification relates to their migra-
tory choices, are not completely eluci-
dated and remain the subject of intense
investigation.
Elegant prior studies have demon-
strated that Nkx2-1 is a key transcription
factor governing fundamental aspects of
fate specification and migration of MGE-
derived interneurons. Indeed, constitutive
loss of Nkx2-1 causes the respecification
of MGE (and preoptic area) progenitors,
which acquire a more dorsal, lateral
ganglionic eminence (LGE)-like identity.
This results in a dramatic reduction of
cortical and striatal interneuron popula-
tions, aswell as projection neuron popula-
tionsof theglobuspallidusandother basalforebrain structures (Sussel et al., 1998).
Within progenitors of MGE identity,
Nkx2-1 continues to be important, as the
generation of both GABAergic and cholin-
ergic interneuron classes is controlled
downstream of it. In this context, Nkx2-1
regulates the expression of either Lhx6
or Lhx8 to instruct the acquisition of
GABAergic and cholinergic IN fates,
respectively (Wonders and Anderson,
2006, Fragkouli et al., 2009).
More recent work has demonstrated,
however, that Nkx2-1 function is finely
temporally and spatially tuned. Condi-
tional removal of Nkx2-1 from the MGE
at different developmental time points
(and different stage of differentiation)
demonstrates that early in development
(between E9.5 and E10.5) Nkx2-1 is
necessary to enable the generation of
MGE-derived cortical and striatal inter-
neurons rather than LGE derivatives.
However, genetic ablation of Nkx2-1 at
later developmental stages (E12.5) does
not change the total number of INs
produced but it affects the generation of
specific classes of cortical interneurons,
favoring the formation of CR+/VIP+
cortical IN subtypes, which normally
would have a caudal ganglionic eminence
(CGE) origin (Butt et al., 2008). Finally,
after initial fate specification, postmitotic
levels of Nkx2-1 expression continue to
affect cortical interneuron development,
as key guidance receptors (i.e.,Neuropilin
2) that are necessary for cortical INs to be
repelled from the striatum and migrate to
the cortex are directly and negatively
regulated by Nkx2-1 (No´brega-Pereira
et al., 2008).
Together, these prior studies illustrate
the importance of finely controlled regula-
tion of Nkx2-1 expression for normal fateNeuronspecification and migration of cortical
GABAergic interneurons. However, the
molecular mechanisms acting upstream
of Nkx2-1 and responsible for this level of
control have been unknown. Two articles
in this issue (McKinsey et al., 2013; van
den Berghe et al., 2013) independently
identify the transcription factor Sip1 (also
known as Zfhx1b and Zeb2) as a new
regulator of cortical interneuron differ-
entiation and dorsal migration acting
upstream of Nkx2-1.
‘‘Should I Stay or Should I Go’’? Sip1
Control over Interneuron Migration
to the Cerebral Cortex
Upon fate specification in the MGE,
cortical interneurons must initiate dorsally
directed migration to reach the cortex.
Downregulation of Nkx2-1 is necessary in
this context to ensure repulsion from the
developing striatum (No´brega-Pereira
et al., 2008). Striatal interneurons, on the
contrary, maintain high levels of Nkx2-1
to be able to invade the striatum. How is
tuning of Nkx2-1 levels differentially
achieved in these two interneuron popula-
tions? New work now provides evidence
that the transcription factor Sip1, which
was previously known for its non-cell-
autonomous role in controlling neurogen-
esis of excitatory projection neurons in
the cerebral cortex (Seuntjens et al.,
2009), is necessary to modulate Nkx2-1
levels within migrating cortical interneu-
rons and to control their migration to the
cortex (McKinsey et al., 2013, van den
Berghe et al., 2013).
Within the ventral telencephalon, Sip1 is
expressed at progressively increased
levels within postmitotic interneurons as
they migrate toward the cortex, and its
expression is maintained once they enter77, January 9, 2013 ª2013 Elsevier Inc. 1
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Figure 1. Sip1 Is Required for Cortical Interneuron Differentiation
and Migration to the Cerebral Cortex
(A) McKinsey et al. (2013) propose a model whereby in cortical interneurons
Dlx1/2 induce Sip1 expression, which in turn negatively regulates Nkx2-1
levels. van den Berghe et al. (2013) show that Sip1 represses the expression
of the guidance receptor Unc5b.
(B) In the absence of Sip1, up to 90% of PV+ and Sst+ cortical interneurons
(MGE derived) fail to reach the cortex and stall in the ventral telencephalon.
In addition, ectopically located interneurons downregulate markers of
cortical interneurons and acquire molecular features of striatal GABAergic
interneurons.
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Previewsthe cortical plate. Using
several Cre lines to condition-
ally delete Sip1 in the ventral
telencephalon, both groups
find a striking reduction in the
number of PV+ and Sst+
(MGE-derived) interneurons
that reach the cortex in these
mutants (Figure 1). This is
accompanied by the ectopic
accumulation of interneurons
in the striatum (McKinsey
et al., 2013) and other regions
of the ventral telencephalon
(van den Berghe et al., 2013).
Interestingly, molecular anal-
ysis demonstrates that ex-
pression of Nkx2-1 remains
elevated in most tangentially
migrating interneurons upon
loss of Sip1, thus suggest-
ing that in the absence of this
transcription factor cortical
interneurons are unable to
downregulate Nkx2-1, a
necessary requirement to
reach the cortex (No´brega-
Pereira et al., 2008).
Of note, while Nkx2-1 is
required for the generation of
both GABAergic and cho-
linergic interneurons, loss of
Sip1 only affects GABAergic
interneurons, controlling theirdecision to migrate to the cortex or locate
in the striatum. Closely related Nkx2-1+/
Lhx8+ striatal cholinergic interneurons
remain unaffected in the absence of Sip1
(McKinsey et al., 2013). It is tempting to
speculate that different populations of
progenitors might exist in the MGE that
specify interneurons of the GABAergic
and cholinergic fate. Alternatively,
Sip1 might not regulate Nkx2-1 directly,
and rather require additional cofactors,
which in turn would determine its
specificity of function in GABAergic
interneurons. Further work that eluci-
dates at the single-cell level the temporal
and spatial regulation of Sip1 expression
and elucidation of the molecular logic
that governs expression of Sip1 down-
stream targets should clarify these
possibilities.
While the exact molecular mechanisms
of Sip1 action remain to be elucidated,
McKinsey and colleagues demonstrate
that Sip1 itself is regulated downstream2 Neuron 77, January 9, 2013 ª2013 Elsevierof Dlx2, which binds directly to two
conserved enhancers necessary for Sip1
expression. The data support a possible
model by which Dlx2 positively regulates
expression of Sip1, which in turn nega-
tively regulates (directly or indirectly)
Nkx2-1 levels to control migration of inter-
neurons to the cortex (Figure 1A).
However, other factors are at play in
controlling this complex process. van
den Berghe and collaborators find that at
least part of Sip1 control over interneuron
migration to the cortex is mediated by the
Netrin receptorUnc5b, which is repressed
downstreamofSip1 (Figure 1A). Indeed, at
the functional level, downregulation of
Unc5b alone can partially rescue the
migratory defects displayed by cortical
interneurons that lack Sip1. In the future
it will be interesting to investigate how
expression of Unc5b and other guidance
receptors, most prominently Neuropilin
2, is coordinated to finely modulate the
migration of interneurons to the cortex.Inc.Beyondmechanistic expla-
nations, the work defines
Sip1 as a novel transcription
factor necessary to enable
MGE-derived INs to populate
the cortex.
‘‘Dazed and Confused’’:
Loss of Sip1 and the
Identity Crisis for
Cortical Interneurons
Conditional null mutant mice
for Sip1 survive for over three
weeks postnatally, offering
an opportunity to investigate
the identity acquired by
cortical interneurons mis-
routed to the subpallium in
Sip1 mutants. Both van den
Berghe et al. (2013) and
McKinsey et al. (2013)
perform molecular profiling
of neurons isolated from the
subpallium of Sip1 condi-
tional mutants. While,
perhaps unsurprisingly, the
levels of differential expres-
sion reported for some genes
differ slightly between the two
studies (at least in part due to
different methods of tissue
collection), overall the data
show that several transcripts
normally present in corticalinterneurons are downregulated in the
mutants, while some genes preferentially
expressed in striatal GABAergic interneu-
rons appear upregulated. Downregulated
genes include Cxcr4, Gria1, Ets1, Cxcr7,
Grik1, Cntnap4, Grip1, Chl1, Cacng2,
Csdc2, and Scn1a (van den Berghe
et al., 2013), known to be enriched in,
albeit not restricted to, developing cortical
interneurons (Batista-Brito et al., 2008,
Marsh et al., 2008, McKinsey et al.,
2013). Similarly,Cux2,whichpreferentially
labels cortical versus striatal interneurons,
was reduced. In contrast, Nkx2-1, whose
expression normally remains high in stria-
tal interneurons but is downregulated in
cortical interneurons, and NPY, which at
E15.5 preferentially labels striatal inter-
neurons, were upregulated in the mutant
subpallium.
Despite the fact that a unique com-
binatorial code of molecules does not
currently exist that can distinguish striatal
and cortical GABAergic interneurons, this
Neuron
Previewsmolecular analysis shows not only that in
the absence of Sip1 cortical INs fail to
migrate to the cortex and ectopically posi-
tion in the striatum,but also that in this new
environment they fail to acquire or main-
tain molecular features of cortical INs,
gaining some traits of striatal GABAergic
interneurons (Figure 1B). Consistent with
this model, McKinsey and colleagues
identify the Substance P receptor TacR1
as being selectively expressed in striatal
interneurons compared to cortical inter-
neurons and show that its levels are
increased in the Sip1 mutant striatum.
Notably, markers of cholinergic striatal
interneurons (Lhx8, Gbx2, Isl1, and TrkA)
and those of the globus pallidus (Kcdt12,
Gbx2, and Kcnmb4) remain unchanged,
suggesting that a switch of fate between
GABAergic populations of cortical and
striatal interneurons has occurred in the
mutants.
The observed molecular changes could
be due to a direct, cell-autonomous effect
of Sip1 loss, though one cannot exclude a
non-cell-autonomous effect of the new,
ectopic environment to which the ‘‘redir-
ected’’ interneurons are now exposed.
The fact that the small percentage of
cortical neurons that manage to reach
the cortex acquire expression of cortical
IN features suggests that the environment
of the striatummight also be playing a role
in instructing this switch of fate. From this
perspective, it would be interesting in the
future to understand whether Sip1mutant
interneurons for whichmigration has been
rescued and which can thus reach the
cortex, for example by downregulation
of Unc5b, are still able to become bona
fide cortical interneurons.
Finally, the changes in molecular iden-
tity observed in cortical interneurons
upon loss of Sip1 suggest that this tran-
scription factor might have been impor-
tant for the evolution of cortical inhibitory
circuitry. Although mammalian brains are
the only, among vertebrates, with a six-
layer cerebral cortex, lower vertebrates
might have already devised mechanisms
to sort GABAergic interneurons fated to
the subpallium from those destined to
the pallium. Further comparative molec-
ular analysis of different species may
shed light on the evolutionary relevanceof Sip1 for the acquisition of cortical
interneurons.
‘‘With or without You’’: Reduction of
Cortical Interneurons and Mowat-
Wilson Syndrome
Many neurodevelopmental disorders
and mental illnesses are caused by a
malformed or malfunctioning cortical
GABAergic circuit. This testifies to the
importance of balanced cortical circuitry
for high-level cortical function and justifies
efforts to unravel the molecular mecha-
nisms governing interneuron specifica-
tion, positioning, and connectivity in the
cortex. For some of these pathologies a
genetic etiology is known while for others
it remains elusive.
It is intriguing that mutations in the Sip1
gene locus (2q22-q23) have been re-
ported in patients suffering from a very
complex syndrome known as Mowat-Wil-
son Syndrome (MWS). Indeed, since the
first description of this disease in 1998,
more than 100 Sip1 mutations (including
deletions) have been reported from
patients all over the world (Mowat et al.,
2003, Garavelli and Mainardi, 2007). This
is interesting, because while patients
withMWS showdifferent levels of intellec-
tual disability and motor impairment,
seizures and abnormal EEGs have been
reported in 90% of cases and thus repre-
sent a prominent clinical sign of this
syndrome. In light of the role now reported
for Sip1 in controlling cortical interneuron
differentiation andmigration to the cortex,
clinical symptoms of these patients could
be explained by a decrease of two main
populations ofMGE-derived cortical inter-
neurons, PV+ and Sst+.
Sip1 is known to also work non-cell-
autonomously to control the rate of excit-
atory neuron birth in the cortex (Seuntjens
et al., 2009), and a role for this protein as
a regulator of oligodendrocyte differentia-
tion and myelination has also been
recently reported (Weng et al., 2012).
Even with the caveat that disturbed excit-
atory projection neuron development
could result in an abnormal cortical inhibi-
tory circuit (Hevner et al., 2004, Lodato
et al., 2011) and that defectivemyelination
has been associated to epileptic pheno-
types in mice, the new work on the roleNeuronof Sip1 over development of cortical inter-
neurons centrally contributes to the
understanding of MWS pathology and
etiology and informs approaches for
future therapeutic intervention.
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